69.2 F
New York
Wednesday, May 18, 2022

Profound [NASDAQ: PROF] Inks A Co-Development Contract With GE Healthcare

Must read

Profound Medical Corp [NASDAQ: PROF] reported that the company has signed a co-development contract with GE Healthcare.  The companies settled on a global license that will allow Profounds TULSA PRO systems with GE MRI scanners. Moreover, This partnership enables Profounds to extends its portfolio to interface with a substantial portion of GE’s new MRI scanners currently installed worldwide.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


“The company is glad to expand the potential of MRI scanners that sustains TULSA PRO-Technology. The addition of GE gives our clients more feasibility to use MRI hardware of their choice. We are thankful to our existing customers for embracing TULSA PRO. Furthermore, we look ahead to delivering the benefit of this technology broadly available.” Arun Menawat CEO Profound.

“Profund’s sensational noninvasive treatment technology holds the ability to bring substantial help to cancer patients. GE has served long in therapy guidance and control by applying MR. Additionally, we are excited to add TULSA PRO abilities to deliver our clients more and better possibilities to treat their patients.” General manager GE MR beyond segment.

More articles

Latest article